PRISM BioLab has collaborated with Receptor.AI to integrate AI and physics-guided technologies in the discovery of orally ...

Curatis has signed an exclusive licensing and development agreement with Neupharma for corticorelin to treat peritumoral ...

In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation ...

These UK-led efforts to support foreign infectious disease trials come after the US pulled foreign research aid to home in on ...

J&J has announced the US FDA approval for the combination of Tecvayli and Darzalex Faspro for adults with RRMM.

The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term ...

This ends a drawn out legal battle brought by Genevant and Arbutus against Moderna under a week before the jury trial was set ...

Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to CAR designs tailored for myeloid ...

Dubai is building life sciences clusters and research hubs, aiming to be a resilient healthcare and innovation center in a region facing ongoing conflict.

Esperion is to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a ...

GlobalData Healthcare recently attended the World Evidence, Pricing and Access (EPA) congress in Amsterdam on 3-4 March 2026.

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing DMTs for Parkinson’s disease.